Similar articles

• Effect of tolamolol versus propranolol on cardiovascular haemodynamics in patients with angina.

  Aronow WS, March H, Vangrow JS, Cassidy J, Kern JC, Khemka M, Vawter M, Pagano J. Aronow WS, et al. Br Heart J. 1974 Nov;36(11):1078-81. doi: 10.1136/hrt.36.11.1078. Br Heart J. 1974. PMID: 4155953 Free PMC article. Clinical Trial. No abstract available.
• Clinical trial of a new beta-receptor blocking agent, tolamolol, in angina pectoris.

  Nordenfelt I, Olsson L, Persson S. Nordenfelt I, et al. Eur J Clin Pharmacol. 1974;7(3):157-62. doi: 10.1007/BF00560375. Eur J Clin Pharmacol. 1974. PMID: 4152812 Clinical Trial. No abstract available.
• [Treatment of angina pectoris with beta-receptor blockaders a slow-releasing isosorbide dinitrate preparation].

  Kappenberger L, Fellmann H, Nager F. Kappenberger L, et al. Schweiz Med Wochenschr. 1973 Dec 15;103(50):1789-92. Schweiz Med Wochenschr. 1973. PMID: 4149035 Clinical Trial. German. No abstract available.
• [Therapy and differential therapy with beta sympathicolytic drugs].

  Frisch P. Frisch P. Med Klin. 1975 Oct 17;70(42):1682-7. Med Klin. 1975. PMID: 241898 Review. German. No abstract available.
• Combined therapy with beta-adrenergic blockers and calcium-antagonists in patients with ischemic heart disease.

  Winniford MD, Hillis LD. Winniford MD, et al. Herz. 1982 Aug;7(4):243-9. Herz. 1982. PMID: 6127300 Review. No abstract available.